Recent trends in U.S. breast cancer incidence, survival, and mortality rates

Journal of the National Cancer Institute

Volumn 88, Issue 21, 1996, Pages 1571-1579

  Chu, Kenneth C ^a,f   Tarone, Robert E ^e   Kessler, Larry G ^b   Ries, Lynn A G ^c   Hankey, Benjamin F ^c   Miller, Barry A ^c   Edwards, Brenda K ^d  

^a Div of Cancer Prev and Control   (United States)

^b Applied Research Branch   (United States)

^c Cancer Statistics Branch   (United States)

^d Cancer Control Research Program

^e NATIONAL CANCER INSTITUTE   (United States)

^f NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; INCIDENCE; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; SURVIVAL RATE; UNITED STATES;

EID: 0029903615     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/88.21.1571     Document Type: Article

References (46)

1. Shapiro S, Venet W, Strax P, Venet L. Ten- to fourteen-year effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.
2. Tahar L, Fagerberg CJ, Gad A, Baldetorp L, Holmberg LH, Grontoft O, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet 1985;1:829-32.
3. American Cancer Society. Guidelines for the cancer-related checkup: recommendations and rationale. CA Cancer J Clin 1980;30:1-50.
4. Mammography guidelines 1983: background statement and update of cancer-related checkup guidelines for breast cancer detection in asymptomatic women ages 40 to 49. CA Cancer J Clin 1983;33:255.
5. Brown ML, Kessler LG, Rueter FG. Is the supply of mammography machines outstripping need and demand? An economic analysis [see comment citations in Medline]. Ann Intern Med 1990;113:547-52.
6. Breen N, Kessler L. Changes in the use of screening mammography: evidence from the 1987 and 1990 National Health Interview Surveys. Am J Public Health 1994;84:62-7.
7. Wald NJ, Chamberlain J, Hackshaw A. Report of the European Society of Mastology Breast Cancer Screening Evaluation Committee (1993). Breast 1993;2:209-16.
8. Smart CR, Hendrick RE, Rutledge JH, Smith RA. Benefit of mammography screening in women ages 40-49 years. Cancer 1995;75:1619-26.
9. Bonadonna G. Brusamolino E, Valagussa P, Rossi A, Brugnatelli L, Brambilla C, et al. Combination chemotherapy as an adjuvant treatment in operable breast cancer. N Engl J Med 1976;294:405-10.
10. Controlled trial of tamoxifen as adjuvant agent in management of early breast cancer. Interim analysis at four years by Nolvadex Adjuvant Trial Organisation. Lancet 1983;1:257-61.
11. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Bethesda, Maryland, September 9-11, 1985. NCI Monogr 1986;1:1-159.
12. National Cancer Institute: Clinical alert from the National Cancer Institute. Bethesda (MD): National Cancer Institute. May 18, 1988.
13. Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy. 133 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Early Breast Cancer Trialists' Collaborative Group [see comment citations in Medline]. Lancet 1992;339:1-15,71-85.
14. Smigel K. Breast cancer death rates decline for white women [news]. J Natl Cancer Inst 1995;87:173.
15. Beral V, Hermon C, Reeves G, Peto R. Sudden fall in breast cancer death rates in England and Wales [letter] [see comment citation in Medline]. Lancet 1995;345:1642-3.
16. Quinn M, Allen E. Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. United Kingdom Association of Cancer Registries [see comment citations in Medline]. BMJ 1995;311:1391-5.
17. National Cancer Institute of Canada. Canadian Cancer Statistics 1996. Toronto, Canada, 1996.
18. Blot WJ, Devesa SS, Fraumeni JF Jr. Declining breast cancer mortality among young American women. J Natl Cancer Inst 1987;78:451-4.
19. Tarone RE, Chu KC. Implications of birth cohort patterns in interpreting trends in breast cancer rates. J Natl Cancer Inst 1992;84:1402-10.
20. Young JL Jr, Percy CL, Asire AJ, Surveillance, Epidemiology, and End Results: incidence and mortality data, 1973-1977. NCI Monogr 1981;57:1-1082.
21. SEER Program, Surveillance, Epidemiology, and End Results Program, National Cancer Institute, Bethesda (MD).
22. Kosary CL, Ries LA, Miller BA, Hankey BF, Harras A, Edwards BK, editors. SEER Cancer Statistics Review, 1973-1992: tables and graphs. Bethesda (MD): National Cancer Institute; 1995: DHHS Publ No. (NIH)96-2789.
23. Horm JW, Asire AJ, Young JL, Pollack ES, SEER Program: cancer incidence and mortality in the United States 1973-1981. Bethesda (MD): National Cancer Institute; 1984; DHHS Publ No. (NIH)85-1837.
24. Miller BA, Ries LA, Hankey BF, Kosary CL, Harras A, Devesa SS, et al., editors. SEER Cancer Statistics Review, 1973-1990. Bethesda (MD): National Cancer Institute; 1993; DHHS Publ No. (NIH)93-2789.
25. Ederer F, Axtell LM, Cutler SJ. The relative survival rates: a statistical methodology. Natl Cancer Inst Monogr 1961;6:101-21.
26. American Joint Committee of Cancer. Beahrs OH, Henson DE, Hutter RV, Kennedy BJ. Manual for staging of cancer, 4th ed. Philadelphia, Lippincott, 1992.
27. The International Classification of Diseases, 9th Revision, DHHS Publ No. (PHS)80-1260, US Department of Health and Human Services, Public Health Service - Health Care Financing Administration.
28. National Center for Health Statistics. Monthly Vital Stat Rep 1995;43:13.
29. Miller BA, Feuer EJ, Hankey BF. Breast cancer [letter] [see comment citation in Medline]. N Engl J Med 1992;327:1756-7.
30. Swanson GM, Ragheb NE, Lin CS, Hankey BF, Miller B, Horn-Ross P, et al. Breast cancer among black and white women in the 1980s. Changing patterns in the United States by race, age, and extent of disease [see comment citation in Medline]. Cancer 1993;72:788-98.
31. Hankey BF, Brinton LA, Kessler LG, Abrams J. Breast. In: Miller BA, Ries LA, Hankey BF, Kosary CL, Harras A, Devesa SS, et al., editors. SEER Cancer Statistics Review: 1973-1990, National Cancer Institute; 1993; DHHS Publ No. (NIH)93-2789.
32. Chu KC. Mortality rates by stage-at-diagnosis. Semin Surg Oncol 1994; 10:7-11.
33. White E, Lee CY, Kristal AR. Evaluation of the increase in breast cancer incidence in relation to mammography use. J Natl Cancer Inst 1990;82: 1546-52.
34. Liff JM, Sung JF, Chow WH, Greenberg RS, Flanders WD. Does increased detection account for the rising incidence of breast cancer? Am J Public Health 1991;81:462-5.
35. Lantz PM, Remington PL, Newcomb PA. Mammography screening and increased incidence of breast cancer in Wisconsin. J Natl Cancer Inst 1991;83:1540-6.
36. Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 1991; 2:67-74.
37. Feuer EJ, Wun ML. How much of the recent rise in breast cancer incidence can be explained by increases in mammography utilization: a dynamic population model approach. Am J Epidemiol 1992;136:1423-36.
38. Miller BA, Feuer EJ, Hankey BF. Recent incidence trends for breast cancer in women and the relevance of early detection: an update [see comment citation in Medline]. CA Cancer J Clin 1993;43:27-41.
39. Howard J. Using mammography for cancer control: an unrealized potential. CA Cancer J Clin 1987;37:33-48.
40. Eddy DM. A computer-based model for designing cancer control strategies. NCI Monogr 1986;2:75-82.
41. Levin DL, Gail MH, Kessler LG, Eddy DM. A model for projecting cancer incidence and mortality in the presence of prevention, screening and treatment programs. NCI Monogr 1986;2:83-93.
42. Fisher B, Anderson S, Redmond CK, Wolmark N, Wickerham DL, Cronin WM. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer [see comment citations in Medline]. N Engl J Med 1995;333:1456-61.
43. Chu KC, Miller BA, Feuer EJ, Hankey BF. A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer. J Clin Epidemiol 1994;47:1451-61.
44. Glick JH. Meeting highlights: adjuvant therapy for breast cancer. J Natl Cancer Inst 1988;80:471-5.
45. National Cancer Institute of Canada. Canadian Cancer Statistics 1993. Toronto, Canada, 1993.
46. Neter J, Wasserman W, Kutner MH. Applied linear statistical models. Richard D. Irwin Inc., Homewood (IL), 3rd ed. 1990.